Intellect Neurosciences, Inc. is a development-stage biopharmaceutical company engaged in the discovery and development of therapeutic products designed to slow, arrest and ultimately prevent Alzheimer's disease and other serious aging disorders.
"10 million baby boomers will develop Alzheimer's disease"
(As stated in 2008 Alzheimer's Disease Facts and Figures published by the Alzheimer's Association)
|
| Legal Notice |
|
Wednesday, September 01, 2010
Intellect Neurosciences to Participate in Rodman & Renshaw 2010 Annual Global Investment Conference in New York
...read more
Thursday, August 19, 2010
Intellect Neurosciences, Inc. CEO Comments on Recent Events in the Development of Novel Alzheimer's Therapies
...read more
Wednesday, August 18, 2010
Intellect Neurosciences, Inc. Locks Database for OX1 Phase 1b Clinical Trial
...read more
|
|
